Skip to main content
OpenTrials
Completed

NCT Number: NCT00487227

Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function

It is often assumed that levels of caffeine found in 'decaffeinated' beverages are below any psychopharmacological threshold. However, recent findings indicate that caffeine doses as low as 9 mg may be psychoactive. The effects of caffeine have also been shown up to 6 hours post-administration. The study aimed to establish the lowest active dose of caffeine, and to ascertain the duration of any effects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The majority of recent caffeine studies have evaluated doses in the range of 75 - 150 mg or 1 - 2 mg/kg (approximately 130 - 260 ml fresh coffee). Such doses produce well characterised effects; including increased 'alertness', and improvements to measures of reaction time and sustained attention. A previous study has demonstrated improvements to performance following 9 mg caffeine, which represents the lowest known psychoactive dose of caffeine. A number of these effects, including elevated salivary caffeine levels, were still apparent at 6 hours post-caffeine consumption (9). Findings showing effects of 12.5 and 9 mg caffeine are important as these are approaching the levels found in decaffeinated beverages, which are assumed to have no behavioural or physiological effects. However, despite extensive research in this area, the lower threshold for psychoactive effects has not been established. A randomised, placebo-controlled, double-blind, balanced crossover study was undertaken. 20 young men and women (13 female, mean age 20.7 years, standard deviation 2.4) undertook computerised assessments of memory and attention and rated subjective mood. Autonomic activity and salivary caffeine were co-monitored. Assessment took place at baseline, 1, 3, 6, and 9 hours post-administration of placebo, 2.5, 5, and 10 mg caffeine (on separate days) administered in 150 ml fruit juice.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • native English speaker

Exclusion criteria

  • pregnancy
  • medication
  • anaemia
  • heart disorder
  • diabetes
  • respiratory disorder
  • epilepsy
  • asthma
  • panic attacks
  • habitual smoking
  • food allergy

Treatment and study plan

Caffeine

Drug

Placebo

Drug

Primary outcomes

  1. Change from baseline speed of attention

    Time frame: 1 hour

  2. Change from baseline speed of attention

    Time frame: 3 hours

  3. Change from baseline speed of attention

    Time frame: 6 hours

  4. Change from baseline speed of attention

    Time frame: 9 hours

Secondary outcomes

  1. Change from baseline accuracy of attention

    Time frame: 1 hour

  2. Change from baseline accuracy of attention

    Time frame: 3 hours

  3. Change from baseline accuracy of attention

    Time frame: 6 hours

  4. Change from baseline accuracy of attention

    Time frame: 9 hours

  5. Change from baseline speed of memory

    Time frame: 1 hour

  6. Change from baseline speed of memory

    Time frame: 3 hours

  7. Change from baseline accuracy of memory

    Time frame: 6 hours

  8. Change from baseline accuracy of memory

    Time frame: 9 hours

  9. Change from baseline subjective mood

    Time frame: 1 hour

  10. Change from baseline subjective mood

    Time frame: 3 hours

  11. Change from baseline subjective mood

    Time frame: 6 hours

  12. Change from baseline subjective mood

    Time frame: 9 hours

  13. Change from baseline blood pressure

    Time frame: 1 hour

  14. Change from baseline blood pressure

    Time frame: 3 hours

  15. Change from baseline blood pressure

    Time frame: 6 hours

  16. Change from baseline blood pressure

    Time frame: 9 hours

  17. Change from baseline heart rate

    Time frame: 1 hour

  18. Change from baseline heart rate

    Time frame: 3 hours

  19. Change from baseline heart rate

    Time frame: 6 hours

  20. Change from baseline heart rate

    Time frame: 9 hours

  21. Change from baseline salivary caffeine levels

    Time frame: 1 hour

  22. Change from baseline salivary caffeine levels

    Time frame: 3 hours

  23. Change from baseline salivary caffeine levels

    Time frame: 6 hours

  24. Change from baseline salivary caffeine levels

    Time frame: 9 hours

Sponsors and collaborators

Lead sponsor

Northumbria University

Other

Registry information

Official study title

Levels of Caffeine Lower Than Those Found in Decaffeinated Beverages Exert Effects on Cognition, Mood, and Autonomic Activity

Important dates

Study start
2005
Study completion
2005
First posted
Jun 18, 2007
Registry last updated
Oct 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.